140 related articles for article (PubMed ID: 16982737)
1. Role of apoptotic nuclease caspase-activated DNase in etoposide-induced treatment-related acute myelogenous leukemia.
Hars ES; Lyu YL; Lin CP; Liu LF
Cancer Res; 2006 Sep; 66(18):8975-9. PubMed ID: 16982737
[TBL] [Abstract][Full Text] [Related]
2. [Rearrangements of the mixed lineage leukemia gene in acute myeloid leukemia].
Zhang LJ; Lu XL; He J; Li Y
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2256-60. PubMed ID: 17064570
[TBL] [Abstract][Full Text] [Related]
3. MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells.
Moneypenny CG; Shao J; Song Y; Gallagher EP
Carcinogenesis; 2006 Apr; 27(4):874-81. PubMed ID: 16377807
[TBL] [Abstract][Full Text] [Related]
4. Genotoxicity of etoposide: greater susceptibility of MLL than other target genes.
Ng A; Taylor GM; Eden OB
Cancer Genet Cytogenet; 2006 Jan; 164(2):164-7. PubMed ID: 16434323
[TBL] [Abstract][Full Text] [Related]
5. Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia.
Chowdhury T; Brady HJ
Blood Cells Mol Dis; 2008; 40(2):192-9. PubMed ID: 17905612
[TBL] [Abstract][Full Text] [Related]
6. Roles of the major apoptotic nuclease-DNA fragmentation factor-in biology and disease.
Widlak P; Garrard WT
Cell Mol Life Sci; 2009 Jan; 66(2):263-74. PubMed ID: 18810317
[TBL] [Abstract][Full Text] [Related]
7. Model for MLL translocations in therapy-related leukemia involving topoisomerase IIβ-mediated DNA strand breaks and gene proximity.
Cowell IG; Sondka Z; Smith K; Lee KC; Manville CM; Sidorczuk-Lesthuruge M; Rance HA; Padget K; Jackson GH; Adachi N; Austin CA
Proc Natl Acad Sci U S A; 2012 Jun; 109(23):8989-94. PubMed ID: 22615413
[TBL] [Abstract][Full Text] [Related]
8. Etoposide and illegitimate DNA double-strand break repair in the generation of MLL translocations: new insights and new questions.
Sung PA; Libura J; Richardson C
DNA Repair (Amst); 2006 Sep; 5(9-10):1109-18. PubMed ID: 16809075
[TBL] [Abstract][Full Text] [Related]
9. Alterations in mRNA expression of apoptosis-related genes BCL2, BAX, FAS, caspase-3, and the novel member BCL2L12 after treatment of human leukemic cell line HL60 with the antineoplastic agent etoposide.
Floros KV; Thomadaki H; Florou D; Talieri M; Scorilas A
Ann N Y Acad Sci; 2006 Dec; 1090():89-97. PubMed ID: 17384250
[TBL] [Abstract][Full Text] [Related]
10. Large complex formation of the inhibitor of caspase-activated DNase.
Kanouchi H; Nishizaki H; Minatogawa Y; Toné S
Apoptosis; 2005 May; 10(3):651-6. PubMed ID: 15909126
[TBL] [Abstract][Full Text] [Related]
11. Stage-specific expression of DNasegamma during B-cell development and its role in B-cell receptor-mediated apoptosis in WEHI-231 cells.
Shiokawa D; Shika Y; Araki S; Sunaga S; Mizuta R; Kitamura D; Tanuma S
Cell Death Differ; 2007 May; 14(5):992-1000. PubMed ID: 17218958
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors.
Brassesco MS; Montaldi AP; Gras DE; Camparoto ML; Martinez-Rossi NM; Scrideli CA; Tone LG; Sakamoto-Hojo ET
Mutagenesis; 2009 Mar; 24(2):153-60. PubMed ID: 19028982
[TBL] [Abstract][Full Text] [Related]
13. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
Kissel CK; Schadendorf D; Röckmann H
Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454
[TBL] [Abstract][Full Text] [Related]
14. Discovery, regulation, and action of the major apoptotic nucleases DFF40/CAD and endonuclease G.
Widlak P; Garrard WT
J Cell Biochem; 2005 Apr; 94(6):1078-87. PubMed ID: 15723341
[TBL] [Abstract][Full Text] [Related]
15. DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis.
Stanulla M; Wang J; Chervinsky DS; Thandla S; Aplan PD
Mol Cell Biol; 1997 Jul; 17(7):4070-9. PubMed ID: 9199342
[TBL] [Abstract][Full Text] [Related]
16. Combined effects of the two reciprocal t(4;11) fusion proteins MLL.AF4 and AF4.MLL confer resistance to apoptosis, cell cycling capacity and growth transformation.
Gaussmann A; Wenger T; Eberle I; Bursen A; Bracharz S; Herr I; Dingermann T; Marschalek R
Oncogene; 2007 May; 26(23):3352-63. PubMed ID: 17130830
[TBL] [Abstract][Full Text] [Related]
17. In vitro cleavage of the MLL gene by topoisomerase II inhibitor (etoposide) in normal cord and peripheral blood mononuclear cells.
Ishii E; Eguchi M; Eguchi-Ishimae M; Yoshida N; Oda M; Zaitsu M; Fujita I; Miyazaki S; Hamasaki Y; Mizutani S
Int J Hematol; 2002 Jul; 76(1):74-9. PubMed ID: 12138900
[TBL] [Abstract][Full Text] [Related]
18. A unique role of the DNA fragmentation factor in maintaining genomic stability.
Yan B; Wang H; Peng Y; Hu Y; Wang H; Zhang X; Chen Q; Bedford JS; Dewhirst MW; Li CY
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1504-9. PubMed ID: 16432220
[TBL] [Abstract][Full Text] [Related]
19. The DFF40/CAD endonuclease and its role in apoptosis.
Widłak P
Acta Biochim Pol; 2000; 47(4):1037-44. PubMed ID: 11996094
[TBL] [Abstract][Full Text] [Related]
20. Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation.
Kawane K; Fukuyama H; Yoshida H; Nagase H; Ohsawa Y; Uchiyama Y; Okada K; Iida T; Nagata S
Nat Immunol; 2003 Feb; 4(2):138-44. PubMed ID: 12524536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
